Soft Capsules Drugs Market, Global Outlook and Forecast 2022-2028

February 2022 | 103 pages | ID: S50DB30B53F6EN
Market Monitor Global

Abstracts

Soft gel capsules are typically a gelatin-based shell, containing a liquid. They can be used as a dosage form for a variety of medicines, including complementary medicines, such as vitamins. In some cases, these medicines may have directions for use that say that they can or should be chewed.

This report contains market size and forecasts of Soft Capsules Drugs in Global, including the following market information:

Global Soft Capsules Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Soft Capsules Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Liquid Core Drugs Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Soft Capsules Drugs include GSK, AstraZeneca, Boehringer Ingelheim, Vertex, Roche, Novartis, Teva, Chiesi and Sumitomo Dainippon, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Soft Capsules Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Soft Capsules Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Soft Capsules Drugs Market Segment Percentages, by Type, 2021 (%)

• Liquid Core Drugs
• Semi-solid Core Drugs

Global Soft Capsules Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Soft Capsules Drugs Market Segment Percentages, by Application, 2021 (%)

• Hospital Pharmacy
• Retail Pharmacy

Global Soft Capsules Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Soft Capsules Drugs Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Soft Capsules Drugs revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Soft Capsules Drugs revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• GSK
• AstraZeneca
• Boehringer Ingelheim
• Vertex
• Roche
• Novartis
• Teva
• Chiesi
• Sumitomo Dainippon
• Merck
• Atrium Innovations
• Abbott
• Blackmores
• The Clorox Company
• Nature Made
• By-health
• A&Z Pharmaceutical

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Soft Capsules Drugs Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Soft Capsules Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL SOFT CAPSULES DRUGS OVERALL MARKET SIZE

2.1 Global Soft Capsules Drugs Market Size: 2021 VS 2028
2.2 Global Soft Capsules Drugs Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Soft Capsules Drugs Players in Global Market
3.2 Top Global Soft Capsules Drugs Companies Ranked by Revenue
3.3 Global Soft Capsules Drugs Revenue by Companies
3.4 Top 3 and Top 5 Soft Capsules Drugs Companies in Global Market, by Revenue in 2021
3.5 Global Companies Soft Capsules Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Soft Capsules Drugs Players in Global Market
  3.6.1 List of Global Tier 1 Soft Capsules Drugs Companies
  3.6.2 List of Global Tier 2 and Tier 3 Soft Capsules Drugs Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Soft Capsules Drugs Market Size Markets, 2021 & 2028
  4.1.2 Liquid Core Drugs
  4.1.3 Semi-solid Core Drugs
4.2 By Type - Global Soft Capsules Drugs Revenue & Forecasts
  4.2.1 By Type - Global Soft Capsules Drugs Revenue, 2017-2022
  4.2.2 By Type - Global Soft Capsules Drugs Revenue, 2023-2028
  4.2.3 By Type - Global Soft Capsules Drugs Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Soft Capsules Drugs Market Size, 2021 & 2028
  5.1.2 Hospital Pharmacy
  5.1.3 Retail Pharmacy
5.2 By Application - Global Soft Capsules Drugs Revenue & Forecasts
  5.2.1 By Application - Global Soft Capsules Drugs Revenue, 2017-2022
  5.2.2 By Application - Global Soft Capsules Drugs Revenue, 2023-2028
  5.2.3 By Application - Global Soft Capsules Drugs Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Soft Capsules Drugs Market Size, 2021 & 2028
6.2 By Region - Global Soft Capsules Drugs Revenue & Forecasts
  6.2.1 By Region - Global Soft Capsules Drugs Revenue, 2017-2022
  6.2.2 By Region - Global Soft Capsules Drugs Revenue, 2023-2028
  6.2.3 By Region - Global Soft Capsules Drugs Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Soft Capsules Drugs Revenue, 2017-2028
  6.3.2 US Soft Capsules Drugs Market Size, 2017-2028
  6.3.3 Canada Soft Capsules Drugs Market Size, 2017-2028
  6.3.4 Mexico Soft Capsules Drugs Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Soft Capsules Drugs Revenue, 2017-2028
  6.4.2 Germany Soft Capsules Drugs Market Size, 2017-2028
  6.4.3 France Soft Capsules Drugs Market Size, 2017-2028
  6.4.4 U.K. Soft Capsules Drugs Market Size, 2017-2028
  6.4.5 Italy Soft Capsules Drugs Market Size, 2017-2028
  6.4.6 Russia Soft Capsules Drugs Market Size, 2017-2028
  6.4.7 Nordic Countries Soft Capsules Drugs Market Size, 2017-2028
  6.4.8 Benelux Soft Capsules Drugs Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Soft Capsules Drugs Revenue, 2017-2028
  6.5.2 China Soft Capsules Drugs Market Size, 2017-2028
  6.5.3 Japan Soft Capsules Drugs Market Size, 2017-2028
  6.5.4 South Korea Soft Capsules Drugs Market Size, 2017-2028
  6.5.5 Southeast Asia Soft Capsules Drugs Market Size, 2017-2028
  6.5.6 India Soft Capsules Drugs Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Soft Capsules Drugs Revenue, 2017-2028
  6.6.2 Brazil Soft Capsules Drugs Market Size, 2017-2028
  6.6.3 Argentina Soft Capsules Drugs Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Soft Capsules Drugs Revenue, 2017-2028
  6.7.2 Turkey Soft Capsules Drugs Market Size, 2017-2028
  6.7.3 Israel Soft Capsules Drugs Market Size, 2017-2028
  6.7.4 Saudi Arabia Soft Capsules Drugs Market Size, 2017-2028
  6.7.5 UAE Soft Capsules Drugs Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 GSK
  7.1.1 GSK Corporate Summary
  7.1.2 GSK Business Overview
  7.1.3 GSK Soft Capsules Drugs Major Product Offerings
  7.1.4 GSK Soft Capsules Drugs Revenue in Global Market (2017-2022)
  7.1.5 GSK Key News
7.2 AstraZeneca
  7.2.1 AstraZeneca Corporate Summary
  7.2.2 AstraZeneca Business Overview
  7.2.3 AstraZeneca Soft Capsules Drugs Major Product Offerings
  7.2.4 AstraZeneca Soft Capsules Drugs Revenue in Global Market (2017-2022)
  7.2.5 AstraZeneca Key News
7.3 Boehringer Ingelheim
  7.3.1 Boehringer Ingelheim Corporate Summary
  7.3.2 Boehringer Ingelheim Business Overview
  7.3.3 Boehringer Ingelheim Soft Capsules Drugs Major Product Offerings
  7.3.4 Boehringer Ingelheim Soft Capsules Drugs Revenue in Global Market (2017-2022)
  7.3.5 Boehringer Ingelheim Key News
7.4 Vertex
  7.4.1 Vertex Corporate Summary
  7.4.2 Vertex Business Overview
  7.4.3 Vertex Soft Capsules Drugs Major Product Offerings
  7.4.4 Vertex Soft Capsules Drugs Revenue in Global Market (2017-2022)
  7.4.5 Vertex Key News
7.5 Roche
  7.5.1 Roche Corporate Summary
  7.5.2 Roche Business Overview
  7.5.3 Roche Soft Capsules Drugs Major Product Offerings
  7.5.4 Roche Soft Capsules Drugs Revenue in Global Market (2017-2022)
  7.5.5 Roche Key News
7.6 Novartis
  7.6.1 Novartis Corporate Summary
  7.6.2 Novartis Business Overview
  7.6.3 Novartis Soft Capsules Drugs Major Product Offerings
  7.6.4 Novartis Soft Capsules Drugs Revenue in Global Market (2017-2022)
  7.6.5 Novartis Key News
7.7 Teva
  7.7.1 Teva Corporate Summary
  7.7.2 Teva Business Overview
  7.7.3 Teva Soft Capsules Drugs Major Product Offerings
  7.7.4 Teva Soft Capsules Drugs Revenue in Global Market (2017-2022)
  7.7.5 Teva Key News
7.8 Chiesi
  7.8.1 Chiesi Corporate Summary
  7.8.2 Chiesi Business Overview
  7.8.3 Chiesi Soft Capsules Drugs Major Product Offerings
  7.8.4 Chiesi Soft Capsules Drugs Revenue in Global Market (2017-2022)
  7.8.5 Chiesi Key News
7.9 Sumitomo Dainippon
  7.9.1 Sumitomo Dainippon Corporate Summary
  7.9.2 Sumitomo Dainippon Business Overview
  7.9.3 Sumitomo Dainippon Soft Capsules Drugs Major Product Offerings
  7.9.4 Sumitomo Dainippon Soft Capsules Drugs Revenue in Global Market (2017-2022)
  7.9.5 Sumitomo Dainippon Key News
7.10 Merck
  7.10.1 Merck Corporate Summary
  7.10.2 Merck Business Overview
  7.10.3 Merck Soft Capsules Drugs Major Product Offerings
  7.10.4 Merck Soft Capsules Drugs Revenue in Global Market (2017-2022)
  7.10.5 Merck Key News
7.11 Atrium Innovations
  7.11.1 Atrium Innovations Corporate Summary
  7.11.2 Atrium Innovations Business Overview
  7.11.3 Atrium Innovations Soft Capsules Drugs Major Product Offerings
  7.11.4 Atrium Innovations Soft Capsules Drugs Revenue in Global Market (2017-2022)
  7.11.5 Atrium Innovations Key News
7.12 Abbott
  7.12.1 Abbott Corporate Summary
  7.12.2 Abbott Business Overview
  7.12.3 Abbott Soft Capsules Drugs Major Product Offerings
  7.12.4 Abbott Soft Capsules Drugs Revenue in Global Market (2017-2022)
  7.12.5 Abbott Key News
7.13 Blackmores
  7.13.1 Blackmores Corporate Summary
  7.13.2 Blackmores Business Overview
  7.13.3 Blackmores Soft Capsules Drugs Major Product Offerings
  7.13.4 Blackmores Soft Capsules Drugs Revenue in Global Market (2017-2022)
  7.13.5 Blackmores Key News
7.14 The Clorox Company
  7.14.1 The Clorox Company Corporate Summary
  7.14.2 The Clorox Company Business Overview
  7.14.3 The Clorox Company Soft Capsules Drugs Major Product Offerings
  7.14.4 The Clorox Company Soft Capsules Drugs Revenue in Global Market (2017-2022)
  7.14.5 The Clorox Company Key News
7.15 Nature Made
  7.15.1 Nature Made Corporate Summary
  7.15.2 Nature Made Business Overview
  7.15.3 Nature Made Soft Capsules Drugs Major Product Offerings
  7.15.4 Nature Made Soft Capsules Drugs Revenue in Global Market (2017-2022)
  7.15.5 Nature Made Key News
7.16 By-health
  7.16.1 By-health Corporate Summary
  7.16.2 By-health Business Overview
  7.16.3 By-health Soft Capsules Drugs Major Product Offerings
  7.16.4 By-health Soft Capsules Drugs Revenue in Global Market (2017-2022)
  7.16.5 By-health Key News
7.17 A&Z Pharmaceutical
  7.17.1 A&Z Pharmaceutical Corporate Summary
  7.17.2 A&Z Pharmaceutical Business Overview
  7.17.3 A&Z Pharmaceutical Soft Capsules Drugs Major Product Offerings
  7.17.4 A&Z Pharmaceutical Soft Capsules Drugs Revenue in Global Market (2017-2022)
  7.17.5 A&Z Pharmaceutical Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Soft Capsules Drugs Market Opportunities & Trends in Global Market
Table 2. Soft Capsules Drugs Market Drivers in Global Market
Table 3. Soft Capsules Drugs Market Restraints in Global Market
Table 4. Key Players of Soft Capsules Drugs in Global Market
Table 5. Top Soft Capsules Drugs Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Soft Capsules Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Soft Capsules Drugs Revenue Share by Companies, 2017-2022
Table 8. Global Companies Soft Capsules Drugs Product Type
Table 9. List of Global Tier 1 Soft Capsules Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Soft Capsules Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Soft Capsules Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Soft Capsules Drugs Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Soft Capsules Drugs Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Soft Capsules Drugs Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Soft Capsules Drugs Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Soft Capsules Drugs Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Soft Capsules Drugs Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Soft Capsules Drugs Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Soft Capsules Drugs Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Soft Capsules Drugs Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Soft Capsules Drugs Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Soft Capsules Drugs Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Soft Capsules Drugs Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Soft Capsules Drugs Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Soft Capsules Drugs Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Soft Capsules Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Soft Capsules Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Soft Capsules Drugs Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Soft Capsules Drugs Revenue, (US$, Mn), 2023-2028
Table 30. GSK Corporate Summary
Table 31. GSK Soft Capsules Drugs Product Offerings
Table 32. GSK Soft Capsules Drugs Revenue (US$, Mn), (2017-2022)
Table 33. AstraZeneca Corporate Summary
Table 34. AstraZeneca Soft Capsules Drugs Product Offerings
Table 35. AstraZeneca Soft Capsules Drugs Revenue (US$, Mn), (2017-2022)
Table 36. Boehringer Ingelheim Corporate Summary
Table 37. Boehringer Ingelheim Soft Capsules Drugs Product Offerings
Table 38. Boehringer Ingelheim Soft Capsules Drugs Revenue (US$, Mn), (2017-2022)
Table 39. Vertex Corporate Summary
Table 40. Vertex Soft Capsules Drugs Product Offerings
Table 41. Vertex Soft Capsules Drugs Revenue (US$, Mn), (2017-2022)
Table 42. Roche Corporate Summary
Table 43. Roche Soft Capsules Drugs Product Offerings
Table 44. Roche Soft Capsules Drugs Revenue (US$, Mn), (2017-2022)
Table 45. Novartis Corporate Summary
Table 46. Novartis Soft Capsules Drugs Product Offerings
Table 47. Novartis Soft Capsules Drugs Revenue (US$, Mn), (2017-2022)
Table 48. Teva Corporate Summary
Table 49. Teva Soft Capsules Drugs Product Offerings
Table 50. Teva Soft Capsules Drugs Revenue (US$, Mn), (2017-2022)
Table 51. Chiesi Corporate Summary
Table 52. Chiesi Soft Capsules Drugs Product Offerings
Table 53. Chiesi Soft Capsules Drugs Revenue (US$, Mn), (2017-2022)
Table 54. Sumitomo Dainippon Corporate Summary
Table 55. Sumitomo Dainippon Soft Capsules Drugs Product Offerings
Table 56. Sumitomo Dainippon Soft Capsules Drugs Revenue (US$, Mn), (2017-2022)
Table 57. Merck Corporate Summary
Table 58. Merck Soft Capsules Drugs Product Offerings
Table 59. Merck Soft Capsules Drugs Revenue (US$, Mn), (2017-2022)
Table 60. Atrium Innovations Corporate Summary
Table 61. Atrium Innovations Soft Capsules Drugs Product Offerings
Table 62. Atrium Innovations Soft Capsules Drugs Revenue (US$, Mn), (2017-2022)
Table 63. Abbott Corporate Summary
Table 64. Abbott Soft Capsules Drugs Product Offerings
Table 65. Abbott Soft Capsules Drugs Revenue (US$, Mn), (2017-2022)
Table 66. Blackmores Corporate Summary
Table 67. Blackmores Soft Capsules Drugs Product Offerings
Table 68. Blackmores Soft Capsules Drugs Revenue (US$, Mn), (2017-2022)
Table 69. The Clorox Company Corporate Summary
Table 70. The Clorox Company Soft Capsules Drugs Product Offerings
Table 71. The Clorox Company Soft Capsules Drugs Revenue (US$, Mn), (2017-2022)
Table 72. Nature Made Corporate Summary
Table 73. Nature Made Soft Capsules Drugs Product Offerings
Table 74. Nature Made Soft Capsules Drugs Revenue (US$, Mn), (2017-2022)
Table 75. By-health Corporate Summary
Table 76. By-health Soft Capsules Drugs Product Offerings
Table 77. By-health Soft Capsules Drugs Revenue (US$, Mn), (2017-2022)
Table 78. A&Z Pharmaceutical Corporate Summary
Table 79. A&Z Pharmaceutical Soft Capsules Drugs Product Offerings
Table 80. A&Z Pharmaceutical Soft Capsules Drugs Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Soft Capsules Drugs Segment by Type in 2021
Figure 2. Soft Capsules Drugs Segment by Application in 2021
Figure 3. Global Soft Capsules Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Soft Capsules Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Soft Capsules Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Soft Capsules Drugs Revenue in 2021
Figure 8. By Type - Global Soft Capsules Drugs Revenue Market Share, 2017-2028
Figure 9. By Application - Global Soft Capsules Drugs Revenue Market Share, 2017-2028
Figure 10. By Region - Global Soft Capsules Drugs Revenue Market Share, 2017-2028
Figure 11. By Country - North America Soft Capsules Drugs Revenue Market Share, 2017-2028
Figure 12. US Soft Capsules Drugs Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Soft Capsules Drugs Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Soft Capsules Drugs Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Soft Capsules Drugs Revenue Market Share, 2017-2028
Figure 16. Germany Soft Capsules Drugs Revenue, (US$, Mn), 2017-2028
Figure 17. France Soft Capsules Drugs Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Soft Capsules Drugs Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Soft Capsules Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Soft Capsules Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Soft Capsules Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Soft Capsules Drugs Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Soft Capsules Drugs Revenue Market Share, 2017-2028
Figure 24. China Soft Capsules Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Soft Capsules Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Soft Capsules Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Soft Capsules Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. India Soft Capsules Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Soft Capsules Drugs Revenue Market Share, 2017-2028
Figure 30. Brazil Soft Capsules Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Soft Capsules Drugs Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Soft Capsules Drugs Revenue Market Share, 2017-2028
Figure 33. Turkey Soft Capsules Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Soft Capsules Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Soft Capsules Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Soft Capsules Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. GSK Soft Capsules Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. AstraZeneca Soft Capsules Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Boehringer Ingelheim Soft Capsules Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Vertex Soft Capsules Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Roche Soft Capsules Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Novartis Soft Capsules Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Teva Soft Capsules Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Chiesi Soft Capsules Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Sumitomo Dainippon Soft Capsules Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Merck Soft Capsules Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Atrium Innovations Soft Capsules Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Abbott Soft Capsules Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Blackmores Soft Capsules Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. The Clorox Company Soft Capsules Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Nature Made Soft Capsules Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. By-health Soft Capsules Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 53. A&Z Pharmaceutical Soft Capsules Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)